11/24/20 6:45 AMNYSE : MDTMedtronic Reports Second Quarter Fiscal 2021 Financial ResultsMedtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2021, which ended October 30,RHEA-AIneutral
11/17/20 11:00 AMNYSE : MDTMedtronic to Announce Financial Results for its Second Quarter of Fiscal Year 2021Medtronic plc (NYSE:MDT) announced today that it will report financial results for its second quarter of fiscal year 2021 on Tuesday, November 24, 2020. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be availableRHEA-AIneutral
11/16/20 10:34 AMNYSE : MDTThe New England Journal of Medicine: Medtronic Cryoablation is a Superior Treatment Option for Symptomatic Paroxysmal Atrial Fibrillation Compared to Drug TherapyMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First clinical trial have been published in the New England Journal of Medicine (NEJM). Results from the trial revealRHEA-AIneutral
11/16/20 8:56 AMNYSE : MDTMedtronic Completes Acquisition of MedicreaMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has completed its friendly tender offer for France -based Medicrea International (Euronext Growth Paris: FR0004178572 - ALMED Medicrea; OTCQX Best Market - MRNTF), aRHEA-AIpositive
11/13/20 5:56 PMNYSE : MDTMedtronic Ranked as a Leading Sustainability CompanyMedtronic plc (NYSE: MDT), the global leader in medical technology, today announced that it has been recognized as one of the world's leading companies for sustainability with its inclusion in the Dow Jones Sustainability North America Index (DJSI NorthRHEA-AIvery positive
11/12/20 9:00 AMNYSE : MDTMedtronic Launches InPen(TM) with Real-Time Guardian(TM) Connect CGM Data -- the First Integrated Smart Insulin Pen for People with Diabetes on MDIMedtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of InPen(TM) integrated with real-time 1 Guardian Connect(TM) CGM data. InPen is the first and only FDA-cleared smart 2 insulin pen on the market for people on multipleRHEA-AIvery positive
10/29/20 7:00 AMNYSE : MDTMedtronic Expands ENT Portfolio with FDA Clearance of NIM Vital(TM) Next Generation Intraoperative Nerve Monitoring System and Acquisiton of Ai Biomed Corp.Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital(TM) nerve monitoring system, which enables physicians to identify, confirm, and monitorRHEA-AIneutral
10/26/20 10:00 AMNYSE : MDTMedtronic Venous Stent Receives U.S. FDA Approval to Treat Venous Outflow ObstructionMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for the Abre(TM) venous self-expanding stent system. This device is indicated for use in the iliofemoral veins inRHEA-AIneutral
10/20/20 7:30 AMNYSE : MDTPatients Report Superior, Sustained and Profound Back Pain Relief at 12 Months with DTM(TM) Spinal Cord Stimulation Therapy Using the Medtronic Intellis(TM) PlatformMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced statistically significant 12-month results from a large, multicenter randomized controlled trial (RCT) that further validate the superiority of DTM(TM) Spinal Cord Stimulation (SCS)RHEA-AIneutral
10/18/20 11:30 AMNYSE : MDTNine-Month Results from Medtronic IN.PACT BTK Study Presented in Late-Breaking Clinical Trial Sessions at TCT Connect Annual MeetingMedtronic plc (NYSE: MDT), the global leader in medical technology, today announced the first-ever resultsRHEA-AIneutral
